Colorectal polyps and carcinoma

Published on 11/04/2015 by admin

Filed under Surgery

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 3402 times

27

Colorectal polyps and carcinoma

Introduction

Carcinoma of the colon and rectum is the third most common malignancy in both men and women in Western countries. In the UK, the lifetime risk of colorectal cancer is 5%, although the condition is less common in the developing world. It is rare below the age of 50. Colorectal cancer is not only extremely common, it is also potentially preventable by screening the colon for premalignant lesions, namely adenomatous polyps, in people over 50. Surgery for large bowel cancer is generally rewarding, with high rates of cure achieved by timely resection.

Most cancers arise as a result of a complex interaction between genetic and environmental factors. The Western diet in particular has been incriminated in much of the geographical variation in incidence. About 5% of colorectal cancer is strongly genetically linked. It is important to recognise patients in this small group of inherited colorectal cancer syndromes as there are effective guidelines available for the screening and treatment of patients with these high-risk syndromes.

Most colorectal cancers originate in the glandular mucosa and are therefore histologically adenocarcinomas. Other forms of malignancy in the large bowel such as carcinoid tumour or lymphoma are rare. Squamous carcinomas occur at the anus or in anal canal skin, as do malignant melanomas, but these have an entirely different aetiology and different methods of management; they are discussed in Chapter 30.

Surgery is the mainstay of treatment for colorectal cancer. The common procedures and the complications of large bowel surgery are outlined in this chapter and the different types of intestinal stomas and their indications are described.

Colorectal Polyps

The term polyp is simply a morphological description and describes any localised lesion protruding from the bowel mucosa into the lumen; it does not imply any specific pathology. This conforms to the use of the term elsewhere in the body, e.g. allergic nasal polyps. A simple pathological classification of large bowel polyps is shown in Box 27.1, emphasising the range of polyp types that can occur there.

Adenomatous polyps and adenomas: Polyps are common in the large bowel (Fig. 27.1). The most significant are adenomas (i.e. benign neoplasms) and all have potential for malignant change. In general, it takes 5–10 years to progress to invasive cancer. Early removal prevents progression from adenoma to adenocarcinoma. The process by which the epithelial cells acquire increasingly severe genetic mutations is termed the adenomacarcinoma sequence. Thus, if adenomas are found at endoscopy, all of them should be meticulously removed (Fig. 27.1c) and subjected to histological examination.

Most adenomas are typically pedunculated or sessile (stalkless), allowing easy recognition and removal by diathermy snare. The much less common flat adenomas are particularly found in the Far East. These can be small and recognition at colonoscopy requires special dye-spray techniques. Flat adenomas can be removed by injecting saline into the submucosa to ‘lift’ the flat lesion before excising the abnormal mucosa with diathermy, sometimes in several pieces.

Adenomatous lesions examined histologically display a range of epithelial abnormalities from mild to severe dysplasia, to early invasive cancer. In invasive cancer, the cellular abnormality has breached the muscularis mucosae, from where extension progressively occurs into the submucosa. As a rule, the larger the lesion, the more likely it is to be malignant: only 1% of polyps smaller than 1 cm are malignant whereas about half of those larger than 2.5 cm are malignant.

Even in apparently benign lesions, there may be discrete areas of frank malignancy; so thorough histological examination is needed. When pedunculated lesions are removed by colonoscopic snaring, it is crucial to establish whether there is stalk invasion: if it is clear of cancer, further treatment is not usually required.

Classification of colonic adenomas: Three patterns of lesion are recognised histologically: tubular adenomas, villous adenomas and tubulo-villous adenomas.

Tubular adenomas are small pedunculated or sessile lesions in which the adenoma cells retain a tubular form similar to normal colonic mucosa. Tubular adenomas have the least potential for malignant transformation.

Villous adenomas are usually sessile (no stalk) and frond-like (papilliferous) lesions which tend to secrete mucus. The epithelial component of villous adenoma is more dysplastic than tubular adenoma and there is a correspondingly greater potential for malignancy; as with tubulo-villous adenomas, this potential is proportional to size.

Tubulo-villous adenomas are intermediate between tubular and villous adenomas and comprise the majority of colonic polyps (Fig. 27.1d). Most are pedunculated, and the stalk is covered with normal colonic epithelium. The stalk probably develops by peristalsis dragging the tumour mass distally and can range from about 0.5 to 10 cm long.

Distribution of colorectal adenomas: Although adenomatous polyps can occur in any part of the large bowel, three-quarters of them arise in rectum and sigmoid colon. This exactly parallels the distribution of carcinomas and provides verification that most cancers develop from polyps.

Adenomas often arise singly (particularly villous adenoma) but more than 20% of patients with colonic polyps have multiple polyps, most often tubulo-villous. Patients with proven carcinoma often have coexisting benign adenomas (synchronous), likely to become malignant later if not removed (see Fig. 27.2). This explains why the whole colon should ideally be examined before colectomy, preferably by colonoscopy, and why long-term follow-up after treatment of large bowel cancer should include regular colonoscopy.

Diagnosis and management of colorectal polyps: For symptomatic patients, visualisation of the colon is needed. Most colorectal investigation is somewhat invasive and uncomfortable and the benefits have to be explained to patients, whilst their dignity and privacy is respected as far as possible. In the outpatient clinic, rigid sigmoidoscopy (which actually visualises the rectum) is often performed initially, as nearly half of all polyps lie within reach of the 25 cm instrument. Flexible sigmoidoscopy, usually performed without bowel preparation or after a phosphate enema, reaches past the sigmoid and descending colon to the splenic flexure, covering 75% of the area at risk, but to view the remainder of the bowel requires colonoscopy. Well performed colonoscopy is the ‘gold standard’ investigation: it allows visualisation of the entire large bowel mucosa, and polyps may be removed at the same time. For this reason, it is the first-line investigation in many centres. However, there are disadvantages: it requires a full day’s bowel preparation and the procedure often requires sedation because of the discomfort. Furthermore, colonoscopy carries a 1 : 1000 risk of major haemorrhage or perforation. Sessile, small or flat adenomas in any location can be difficult to recognise even at colonoscopy and these potentially malignant lesions can be missed, especially if bowel preparation has been poor.

An alternative investigation growing in popularity and accuracy is CT colonography. Some studies have shown it to be virtually as sensitive for detecting polyps. It is less invasive and does not require sedation but bowel preparation is needed. Other alternative investigations include double contrast barium enema or unprepared CT scan.

Once an adenomatous polyp is found or a colorectal cancer has been treated, that patient is at risk of forming further polyps elsewhere in the large bowel and needs follow-up colonoscopies. Intervals between colonoscopies are set according to guidelines determined by the number, size and pathology of polyps at each investigation and vary between 1 and 5 years.

Ideally, people at risk would undergo colonoscopic surveillance to detect asymptomatic polyps (as well as invasive cancers) so they can be removed before undergoing malignant change. The UK NHS national bowel cancer screening programme employs faecal occult blood testing every 2 years for people between 60 and 75 years of age. This test has been shown to aid detection of about 50% of asymptomatic cancers and is predicted to reduce mortality from colorectal cancer by at least 15%. Greater reductions could undoubtedly be achieved if patient compliance could be improved, and plans are under way to supplement this programme with a single flexible sigmoidoscopy offered to people aged 55–60.

Adenocarcinoma of Colon and Rectum

Epidemiology of colorectal carcinoma

Table 27.1 shows that colorectal cancer is the third most common cause of death from cancer in the developed world; one in 20 people in the UK suffer from it at some point in their lives and almost a third arise in the rectum. The disease is rare before the age of 50 (except in inherited colorectal cancer syndromes, see later) but common after the age of 60. There is little difference in incidence between the sexes.

Apart from increasing age, diet seems to be an important factor. Since colorectal cancer is more common in developed countries, the Western low-fibre, high-fat diet may increase risk. High intake of meat, fats and ethanol may increase risk, whilst fish, fibre, antioxidants in fruit and vegetables may reduce it. Other protective agents may include aspirin and resistant dietary starch.

Ulcerative colitis, a chronic inflammatory condition of the large bowel (Ch. 28), carries an independent risk of bowel neoplasia. After 10 years of active disease, the cancer risk rises by 1% each year.

Finally, some inherited genetic conditions (discussed below) give rise to colorectal cancer. This explains the higher risk in first-degree relatives of patients with early-onset cancers and why it is important to ask about family history of bowel or other potentially inherited cancers in patients presenting with bowel symptoms.

Inherited conditions causing bowel cancer

A small proportion of bowel cancers result from inherited conditions but they account for a disproportionate number of those presenting when young. Identifying these ‘at risk’ families allows counselling, surveillance and cancer prevention, best done through referral to specialist Familial Colorectal Cancer clinics. These inherited conditions may be divided into the polyposis syndromes, in which sufferers develop large numbers of polyps early in life, likely to undergo malignant change, and hereditary non-polyposis colorectal cancer (HNPCC), in which sufferers have ‘normal’ or low numbers of adenomatous polyps which tend to progress to cancer. The latter is the most common inherited condition predisposing to bowel cancer.

Polyposis syndromes: The most important is familial adenomatous polyposis (FAP), because it is reasonably common (1 : 30 000 people) and because large bowel cancer is inevitable if untreated. An autosomal dominant defect in the APC gene causes 100 or more adenomatous polyps to develop in the large bowel by the mid teens. Affected patients usually have one parent with the condition. Each affected individual is certain to develop colorectal cancer, at an average age of 40, unless preventative measures are taken. Ideally, prophylactic surgery to remove the area at risk should be performed in early adulthood. One option is subtotal colectomy and ileorectal anastomosis which removes nearly all the large bowel but has the retained rectum requires careful very long-term surveillance for malignancy. The alternative is to remove the rectum as well (panproctocolectomy) and perform an ileostomy or an ileal pouch restorative procedure.

Another polyposis syndrome is Peutz–Jeghers syndrome, which causes hamartomatous polyps throughout the gastrointestinal tract. Patients often have freckles around the mouth and on hands, feet and genitalia. Half of these patients are likely to die by the age of 50 because of polyp-related emergencies such as bowel intussusception or cancer. Patients are prone to develop cancers of small and large bowel, stomach, pancreas, testis and breast.

Hereditary non-polyposis colorectal cancer (HNPCC): Hereditary non-polyposis colorectal cancer syndrome (also known as Lynch syndrome) results from defects in mismatch repair genes which repair damaged DNA. The condition carries a 70% lifetime risk of colorectal cancer, but also a substantially increased risk of one or more of other ‘indicator’ cancers such as those of endometrium, ovary, urothelium, small bowel and brain. Families can be difficult to identify because of the diversity of cancers and incomplete genetic penetrance (i.e. not everyone carrying the defect will develop cancer). When HNPCC is suggested by histological characteristics, young age of tumour onset, co-occurrence of tumours or family history, tumour tissue can be screened for markers. If abnormal, formal genetic tests are then undertaken. Those carrying a mutation are best offered colonoscopy every 2 years from the age of 25.

Pathophysiology of colorectal carcinoma

Colorectal carcinomas exhibit a wide range of differentiation which broadly correlates with their clinical behaviour and prognosis (see Fig. 27.5). Most carcinomas are initially exophytic (i.e. protruding into the lumen) and later ulcerate and progressively invade the muscular bowel wall. Eventually, the tumour involves serosa and surrounding structures. Stromal fibrosis may cause luminal narrowing, responsible for the common acute presentation of large bowel obstruction.

Large bowel carcinomas metastasise via lymphatics and the bloodstream, and by the time of diagnosis as many as 25% of patients already have distant metastases (Fig. 27.4). Lymphatic spread is sequential, first to mesenteric nodes and then onward to para-aortic nodes. Occasionally lymph node involvement is directly responsible for the clinical presentation. For example, para-aortic nodes may present as a palpable mass or cause duodenal obstruction. Other enlarged nodes may compress bile ducts in the porta hepatis causing jaundice.

Haematogenous spread usually occurs later than lymphatic spread and is predominantly to the liver and less commonly to other sites such as lung or bone. Systemic manifestations may also occur.

Presentation of large bowel carcinoma

Late presentations with metastases have been discussed. For local disease, the mode of growth and clinical presentation of large bowel cancer depend to some extent on the site.

Change of bowel habit and large bowel obstruction: Colorectal cancers usually secrete mucus and bleed into the lumen, which tends to change the bowel habit towards a looser stool. Thus a recent history of loose stool is more likely to predict cancer than increasing constipation, especially since constipation is so common in the elderly population. Faeces in the left colon are more solid and the intraluminal pressure is higher, thus distal cancers here are more likely to obstruct. Colonic cancers tend to progressively encircle the bowel wall, encroaching on the lumen and producing an annular stenosis, taking perhaps a year to involve each quarter of the circumference.

Large bowel obstruction may be partial or complete. Partial obstruction may present as a change in bowel habit, often noticed as constipation with intermittent ‘overflow’ diarrhoea. Complete obstruction precipitates emergency hospital admission (see Ch. 19).

Clinical signs in suspected colorectal carcinoma

These are illustrated in Figure 27.5. General examination may show features suggesting disseminated malignancy, e.g. obvious cachexia or supraclavicular node enlargement. Abdominal examination is usually normal but may reveal a mass in the colon, hepatomegaly due to metastases, or ascitic fluid. Unfortunately, all these signs represent late and often incurable disease.

Rectal examination is mandatory in all suspected cases as a high proportion of carcinomas occur in the lowest 12 cm and can be reached with an examining finger. In addition, intraperitoneal tumour spread into the pouch of Douglas may be palpable anteriorly through the rectal wall. The degree of fixation of a rectal tumour to surrounding structures can also be evaluated digitally to give some indication of operative difficulty. Finally, the glove should be inspected for stool colour and consistency as well as blood and mucus.

Investigation of suspected colorectal carcinoma

Proctoscopy and rigid or flexible sigmoidoscopy are usually performed at the initial consultation for anyone complaining of bowel symptoms. About 50% of colorectal cancers lie within reach of a rigid sigmoidoscope and 75% within reach of a flexible sigmoidoscope. Lesions can be biopsied through either instrument.

A history of rectal bleeding should be fully investigated in patients over about 45 years and in any patient if the symptoms or signs suggest malignancy. This applies even if a local cause such as haemorrhoids is found, since these are so common that they will often be found coincidentally. Flexible sigmoidoscopy is the initial investigation of choice for rectal bleeding because the causative lesion is probably in the left side of the colon. If a tumour is found, the rest of the bowel must still be examined for synchronous tumours or further polyps.

Where a change in bowel habit (particularly looser stools) or unexplained anaemia is present, any bowel lesion could be left or right sided, and thus the entire colon must be examined by colonoscopy or radiological imaging (Fig. 27.6).

Imaging for staging: When colorectal malignancy is diagnosed, surgery is likely to be necessary to relieve symptoms irrespective of distant spread. Staging is performed to guide oncological planning and counselling. Liver and lung metastases are sought, along with other evidence of spread within the abdomen or to bone. CT scanning is the most useful investigation for these but liver ultrasound scanning may be more sensitive for detecting small liver metastases. MRI scanning can add important information about the precise extent of local spread of rectal cancer.

In a patient presenting as an emergency with complete large bowel obstruction, plain abdominal X-rays often show large bowel dilated by gas down to the level of obstruction and empty of gas beyond it. The level is often at the sigmoid colon or rectosigmoid junction. CT scan or sigmoidoscopy may confirm the likely diagnosis of carcinoma. Similarly, an ‘instant’ Gastrografin enema (i.e. without bowel preparation) can confirm the diagnosis and at the same time exclude pseudo-obstruction.

Management of colorectal carcinoma

Surgical excision is the main treatment. For tumours localised to the bowel wall, resection offers an excellent chance of complete cure; for tumours at a more advanced stage, chemotherapy and radiotherapy may increase the chance of cure. For rectal cancers, chemoradiotherapy may be given preoperatively (known as neoadjuvant therapy) to shrink the tumour to improve the chances of successful surgical removal. Management plans are ideally formulated by multidisciplinary team discussion, where surgeons, oncologists, radiologists, geneticists, palliative care physicians and colorectal specialist nurses discuss all aspects of the case.

For advanced disease, even with very extensive tumours, palliative resection is usually worthwhile to relieve obstruction or to prevent continuing blood loss. In frail patients with metastatic disease in whom any surgery is too risky, a stent can often be placed endoscopically on the left side of the colon to hold the bowel open and relieve obstruction.

Staging of colorectal carcinoma

Staging of colorectal carcinoma influences the desirability of further treatment by chemotherapy or radiotherapy. It also gives an estimate of the statistical probability of surviving 5 years and the likelihood of cure. Final staging of colorectal cancer depends on information from several sources: the findings at laparotomy, histological examination of the resected specimen and the radiological and other imaging for distant organ spread. The two most widely used staging systems are the tumour/node/metastasis (TNM) and Dukes’ classification, outlined in Table 27.2.

Approximately a quarter of all patients with colorectal cancer are incurable at presentation; all of these die within 5 years. Of those that undergo radical surgery with the aim of cure, 50% are alive and well 5 years later. Very few patients surviving 5 years die later of recurrent disease.

Operations for colorectal cancer

The principles of colorectal tumour resection are as follows:

• Before elective operations, the bowel may be prepared by giving a low residue diet and enemas. Oral purgatives are no longer given because of the potential dehydration

• Perioperative prophylactic antibiotics (e.g. gentamicin and metronidazole) are given

• Operative access is achieved laparoscopically, or by laparotomy, usually via a midline incision

• The affected segment of bowel is removed with a margin of normal bowel, usually 5 cm clear each side of the tumour. There must be a good blood supply to the cut ends of bowel to ensure healing so, in practice, lines of resection are determined by the distribution of mesenteric blood vessels (see Fig. 27.7). For example, ascending colon lesions are treated by removing the whole right colon (right hemicolectomy), as the right colic artery must be ligated in order to remove a section of the right colon

• A wedge-shaped section of colonic mesentery is removed with the bowel. This contains the primary field of lymph node drainage. If there are other obvious lymph node metastases, these are usually included in the resection specimen

• Rectal cancers are a special case and an outline of standard operations is given in Figure 27.8. The preferred operation is a sphincter-saving anterior resection of rectum; provided the lower edge of the tumour is 1–2 cm above the anal sphincters, the sphincter can usually be preserved. This operation involves excising the tumour with an appropriate length of bowel plus an intact envelope of fat around it (the mesorectum containing local lymph nodes). The proximal end of bowel is then anastomosed to the distal stump. Alternatively, a pelvic reservoir is created using a J-pouch technique (Fig. 27.8). This has been shown to reduce the frequency and urgency of defaecation without increasing surgical complications. A temporary defunctioning ileostomy or colostomy is sometimes used to aid healing of a low anastomosis. If the sphincter is involved, the entire rectum and anus has to be removed via an abdomino-perineal excision (APE), with the proximal end of bowel brought out as a colostomy

• In most cases, the two cut ends of bowel can be anastomosed without the need for a temporary or permanent colostomy (the indications for stomas and their types and management are described on p. 361 onwards). The method used to rejoin the bowel depends on the site of the anastomosis, the preference of the surgeon and whether there is much disparity in diameter between the ends to be joined. Methods of large bowel anastomosis are shown in Figures 27.9 and 27.10.

• Postoperatively, an ‘enhanced recovery’ program may be employed to encourage early eating and mobilisation (see Ch. 2, p. 26). These have been shown to lower complication rates and shorten hospital stays.

The role of adjuvant radiotherapy and chemotherapy

Adjuvant radiotherapy and chemotherapy is usually offered to patients with Dukes’ C cancers to increase the chance of prolonged survival. There is also a marginal benefit for those with Dukes’ B but the potential advantages have to be weighed against the unpleasant side-effects of treatment. Neoadjuvant chemoradiotherapy is particularly relevant for rectal tumours tethered in the pelvis, where shrinking a large tumour can make it operable. Such therapy may enable the anal sphincter to be preserved by downsizing the tumour. Where rectal tumours extend through the bowel wall, particularly anteriorly, a course of radiotherapy directly before surgery has been shown to reduce local pelvic recurrence. Radiotherapy after surgery is probably less effective and risks radiation damage to small bowel now lying in the pelvis.

For chemotherapy in large bowel cancer, 5-fluorouracil (5-FU) is the chief adjuvant agent; it is often given in combination with its biomodulator, folinic acid.

Management of advanced disease and recurrence

In advanced disease, primary tumour is usually resected to relieve its local effects even with distant metastases. Most of these patients die within 1 or 2 years and only about 1 in 10 survives 3 years. The exception is metastasis confined to the liver (see below), where partial liver resection is enabling prolonged survival in up to 40% of patients.

The liver is the most common site of distant metastasis. Liver metastases may be discovered at imaging for staging before operation, at operation or later as a result of surveillance with ultrasound, CT or blood tumour marker (CEA) estimation. Occasionally there may be one or two metastases confined to a resectable anatomical lobe. These may be excised locally or the affected segment of liver removed by partial hepatectomy. Given the relatively good outcome, liver resections for metastases are increasingly performed. PET scanning can be used to look for occult metastases elsewhere before attempting liver resection.

Patients with liver metastases seldom become jaundiced until the parenchyma is almost completely destroyed or major bile ducts are compressed at the porta hepatis. Specific treatment for this late event is rarely effective, although oral dexamethasone may temporarily reduce metastatic tissue oedema and relieve symptoms. Liver transplantation is fruitless. Colorectal tumours sometimes metastasise to bone, particularly the lumbar spine, and painful lesions may be palliated by radiotherapy.

Metastatic colorectal carcinomas are most often treated with 5-FU, with oxaliplatin as a second-line agent. This can substantially prolong survival and improve quality of life. Colorectal carcinomas also respond to radiotherapy but its use is restricted because the radiation beam cannot avoid damaging nearby small bowel.

‘Recurrences’ within the colon usually represent new cancers arising metachronously from pre-existing or new adenomas. Careful examination of the entire colon before the first operation is likely to reduce such disease. Local recurrence in rectal cancer is now seen in 5–20% but this was more common before neoadjuvant radiotherapy and before the importance of mesorectal excision in anterior resection was realised (see Fig. 27.3). In abdomino-perineal excision, employing a prone patient position in theatre gives a clearer view of the anatomy and allows wider, more oncological margin clearance to be obtained. Recurrences often cause intractable perineal pain; occasionally a fungating mass grows in the anal region or buttocks. These very distressing complications may be palliated to a degree with radiotherapy.

Complications of large bowel surgery

The complications of large bowel surgery are summarised in Box 27.2. Infection arising from faecal contamination is the main early complication of large bowel surgery. Contamination may result from perforation prior to operation, inadvertent faecal spillage during the operation or postoperative anastomotic leakage or breakdown.

Three main types of infection occur: wound infection and/or dehiscence, intraperitoneal abscesses and generalised peritonitis. Intra-abdominal infection carries a high risk of systemic sepsis and multi-organ dysfunction, particularly after emergency operations. All of these infective complications are radically reduced by appropriate use of prophylactic antibiotics.

Stomas

Indications and general principles

It is often necessary to divert the faecal stream to the anterior abdominal wall via a stoma. The effluent is collected in a removable plastic bag attached by adhesive to the abdominal skin. Stomas are named according to the part of the bowel opening on to the abdominal wall, i.e. ileostomy or colostomy. The term urostomy is used for the ileal conduit that connects ureters to the skin surface in patients whose bladder has been removed.

Stomas may be permanent or temporary. Wherever possible, the need for a stoma should be anticipated before operation and discussed with the patient. This is done to obtain informed consent and to prepare the patient for what is often perceived as a ‘fate worse than death’. Specialised stoma therapists assist in planning and aftercare. Before the operation they counsel the patient, who is encouraged to try out a dummy appliance and talk to other stoma patients. The stoma therapist also identifies and marks the most suitable and comfortable site for the stoma appliance. This takes into account the patient’s occupation and leisure activities, clothing and ability for self-care. Colostomies are usually fashioned in the left iliac fossa and ileostomies in the right iliac fossa.

Permanent stomas: These are necessary when there is no distal bowel segment remaining after resection or when for some reason the bowel is not to be rejoined. A colostomy is required after abdomino-perineal excision of a low rectal or anal canal tumour. An ileostomy (see Fig. 27.12) is employed after excision of the whole colon and rectum (pan-proctocolectomy) unless a pouch reconstruction is performed. Sometimes in patients with severe and permanent incontinence, a colostomy may make a better life possible.

Temporary stomas:

Defunctioning stomas: A ‘defunctioning’ stoma (ileostomy or colostomy) may be used to protect a more distal anastomosis at particular risk of leakage or breakdown by preventing intraluminal pressure rises and by diverting the faecal stream. Common examples are a technically difficult low rectal anastomosis (flatus and faeces may leak through the anastomosis), an anastomosis performed after resection of an obstructing lesion (distension may compromise the blood supply), or emergency resection involving unprepared bowel (solid faeces may remain impacted in the lumen). Reversing the temporary stoma to restore bowel continuity is often a relatively simple procedure, usually performed after 3–4 months. Some surgeons like to perform a limited contrast enema to demonstrate anastomotic integrity before closing the stoma.

Types of stoma

The way in which a stoma is fashioned depends on its purpose. The main types of stoma are described below and illustrated in Figure 27.11. Colonic stomas are designed with the bowel mucosa lying almost flush with the skin. Small bowel stomas are fashioned with a ‘spout’ of bowel protruding about 3 cm, to ensure that the irritant small bowel contents enter the ileostomy appliance directly rather than flowing on to the skin (Fig. 27.12).

Loop stoma: This type of stoma is designed so that both proximal and distal segments of bowel drain onto the skin surface (see Fig. 27.11a). This deflects proximal effluent to the skin surface and provides a ‘blow-off’ valve for the distal loop. Loop stomas are used mainly for temporary defunctioning to protect a distal anastomosis. It is straightforward to reanastomose the ends at reversal; the loop is then dropped back into the abdomen. The most common form of loop stoma is the loop ileostomy; occasionally a loop transverse colostomy is used.

Split or ‘spectacle’ stoma: This is the ultimate form of defunctioning stoma but has been largely superseded by the loop stoma. After resection, both proximal and distal bowel ends are brought separately to the skin surface. The proximal end stoma passes stool into a stoma appliance; the distal stoma (or mucous fistula) defunctions the bowel beyond it and produces just a little mucus.

End stoma: This type of stoma is usually permanent. An end colostomy is most commonly used to ‘resite the anus’ on to the abdominal wall after removal of the rectum and anal sphincter (i.e. abdomino-perineal excision—Fig. 27.11b). An ileostomy may be employed after subtotal or pan-proctocolectomy, particularly in fulminant colitis (Fig. 27.11c). Later, some form of reconstruction may be considered, involving an ileal pouch or reservoir in the pelvis composed of loops of ileum sutured side-to-side connected to the anus. The anal sphincter mechanism is preserved so that the patient is usually continent and can control evacuation.

Hartmann’s procedure: end colostomy and rectal stump: Hartmann’s procedure is a relatively safe technique, particularly for less experienced surgeons, and carries less overall risk than primary anastomosis. It is employed after emergency resection of rectosigmoid lesions where primary anastomosis is inadvisable because of obstruction, inflammation or faecal contamination or surgical inexperience. It may be the choice of treatment for frail or debilitated patients. At Hartmann’s operation, the lesion is resected, the proximal bowel is made into an end colostomy (the same as that employed after an abdomino-perineal excision) and the cut end of the distal remnant is closed with sutures or staples (see Fig. 27.11d). Secretions from the residual rectum still pass through the anus. Several months later when local inflammation has resolved, a decision may be made to reconnect the bowel, depending on fitness and the preference of the patient. However, the colostomy is so well tolerated that some patients prefer to keep it permanently rather than undergo another major operation.